NMDA receptor antagonist ketamine impairs feature integration in visual perception

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Meuwese, Julia D I ^a   Van Loon, Anouk M ^a   Scholte, H Steven ^a   Lirk, Philipp B ^a   Vulink, Nienke C C ^a   Hollmann, Markus W ^a   Lamme, Victor A F ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; EYE FIXATION; FEATURE INTEGRATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL LOAD; NORMAL HUMAN; RESPONSE TIME; SEDATION; TASK PERFORMANCE; VISION; VISUAL DISCRIMINATION;

FEMALE; HEALTHY VOLUNTEERS; HUMANS; KETAMINE; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84891477589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079326     Document Type: Article

References (89)

1. Hubel DH, Wiesel TN (1962) Receptive fields, binocular interaction and functional architecture in the cat's visual cortex. J Physiol 160: 106-154. PubMed: 14449617.
2. Felleman DJ, van Essen DC (1991) Distributed hierarchical processing in the primate cerebral cortex. Cereb Cortex 1: 1-47. doi:10.1093/cercor/1.1.1-a. PubMed: 1822724.
3. Angelucci A, Levitt JB, Walton EJS, Hupe J-M, Bullier J et al. (2002) Circuits for local and global signal integration in primary visual cortex. J Neurosci 22: 8633-8646. PubMed: 12351737.
4. Lamme VAF (1995) The Neurophysiology of Figure-Ground Segregation in Primary Visual Cortex. J Neurosci 15: 1605-1615. PubMed: 7869121.
5. Hupé JM, James AC, Payne BR, Lomber SG, Girard P et al. (1998) Cortical feedback improves discrimination between figure and background by V1, V2 and V3 neurons. Nature 394: 784-787. doi: 10.1038/29537. PubMed: 9723617.
6. Zipser K, Lamme VAF, Schiller PH (1996) Contextual modulation in primary visual cortex. J Neurosci 16: 7376-7389. PubMed: 8929444.
7. Scholte HS, Jolij J, Fahrenfort JJ, Lamme VAF (2008) Feedforward and recurrent processing in scene segmentation: electroencephalography and functional magnetic resonance imaging. J Cogn Neurosci 20: 2097-2109. doi:10.1162/jocn.2008.20142. PubMed: 18416684.
8. Gilbert CD, Wiesel TN (1989) Columnar Specificity of Intrinsic Horizontal Connections in Cat Visual Cortex and Corticocortical. J Neurosci 9: 2432-2442. PubMed: 2746337.
9. Gilbert CD (1996) Plasticity in visual perception and physiology. Curr Opin Neurobiol 6: 269-274. doi:10.1016/S0959-4388(96)80083-3. PubMed: 8725971.
10. Lamme VAF, Zipser K, Spekreijse H (1998) Figure-ground activity in primary visual cortex is suppressed by anesthesia. Proc Natl Acad Sci U S A 95: 3263-3268. doi:10.1073/pnas.95.6.3263. PubMed: 9501251.
11. Angelucci A, Bullier J (2003) Reaching beyond the classical receptive field of V1 neurons: horizontal or feedback axons? J Physiol 97: 141-154.
12. Hess RF, Hayes A, Field DJ (2003) Contour integration and cortical processing. J Physiol 97: 105-119. PubMed: 14766137.
13. Kapadia MK, Ito M, Gilbert CD, Westheimer G (1995) Improvement in visual sensitivity by changes in local context: parallel studies in human observers and in V1 of alert monkeys. Neuron 15: 843-856. doi: 10.1016/0896-6273(95)90175-2. PubMed: 7576633.
14. Self MW, Kooijmans RN, Supèr H, Lamme VAF, Roelfsema PR (2012) Different glutamate receptors convey feedforward and recurrent processing in macaque V1. Proc Natl Acad Sci U S A 109: 11031-11036. doi:10.1073/pnas. 1119527109. PubMed: 22615394.
15. Enns JT, Di Lollo V (2000) What's new in visual masking? Trends Cogn Sci 4: 345-352. doi:10.1016/S1364-6613(00)01520-5. PubMed: 10962616.
16. Fahrenfort JJ, Scholte HS, Lamme VAF (2007) Masking disrupts reentrant processing in human visual cortex. J Cogn Neurosci 19: 1488-1497. doi:10.1162/jocn.2007.19.9.1488. PubMed: 17714010.
17. Wokke ME, Sligte IG, Scholte HS, Lamme VAF (2012) Two critical periods in early visual cortex during figure-ground segregation. Brain Behavior 2: 763-777. doi:10.1002/brb3.91. PubMed: 23170239.
18. Boyer JL, Harrison S, Ro T (2005) Unconscious processing of orientation and color without primary visual cortex. Proc Natl Acad Sci U S A 102: 16875-16879. doi:10.1073/pnas.0505332102. PubMed: 16263934.
19. Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA et al. (2005) Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 26: 503-510. doi:10.1016/j.tips.2005.08.006. PubMed: 16126282.
20. Alkire MT, Hudetz AG, Tononi G (2008) Consciousness and anesthesia. Science 322: 876-880. doi:10.1126/science.1149213. PubMed: 18988836.
21. Roelfsema PR, Lamme VAF, Spekreijse H, Bosch H (2002) Figureground segregation in a recurrent network architecture. J Cogn Neurosci 14: 525-537. doi:10.1162/08989290260045756. PubMed: 12126495.
22. Wyatte D, Curran T, O'Reilly R (2012) The limits of feedforward vision: recurrent processing promotes robust object recognition when objects are degraded. J Cogn Neurosci 24: 2248-2261. doi:10.1162/jocn-a-00282. PubMed: 22905822.
23. Li W, Piëch V, Gilbert CD (2008) Learning to link visual contours. Neuron 57: 442-451. doi:10.1016/j.neuron.2007.12.011. PubMed: 18255036.
24. Franks NP, Lieb WR (1994) Molecular and cellular mechanisms of general aneasthesia. Nature 367: 607-614. doi:10.1038/367607a0. PubMed: 7509043.
25. Lumer ED, Edelman GM, Tononi G (1997) Neural dynamics in a model of the thalamocortical system. I. Layers, loops and the emergence of fast synchronous rhythms. Cereb Cortex 7: 207-227. doi:10.1093/cercor/7.3.207. PubMed: 9143442.
26. Dehaene S, Sergent C, Changeux J-P (2003) A neuronal network model linking subjective reports and objective physiological data during conscious perception. Proc Natl Acad Sci U S A 100: 8520-8525. doi: 10.1073/pnas. 1332574100. PubMed: 12829797.
27. Collingridge GL, Bliss TVP (1987) NMDA receptors: their role in longterm potentiation. Tins 10: 288-293.
28. Salin PA, Bullier J (1995) Corticocortical connections in the visual system: structure and function. Physiol Rev 75: 107-154. PubMed: 7831395.
29. Roelfsema PR, van Ooyen A (2005) Attention-gated reinforcement learning of internal representations for classification. Neural Comput 17: 2176-2214. doi:10.1162/0899766054615699. PubMed: 16105222.
30. Johnson RR, Jiang X, Burkhalter A (1996) Regional and laminar differences in synaptic localization of NMDA receptor subunit NR1 splice variants in rat visual cortex and hippocampus. J Comp Neurol 368: 335-355. doi:10.1002/(SICI) 1096-9861(19960506)368:3. PubMed: 8725343.
31. Rosier AM, Arckens L, Orban GA, Vandesande F (1993) Laminar distribution of NMDA receptors in cat and monkey visual cortex visualized by [3H]-MK-801 binding. J Comp Neurol 335: 369-380. doi: 10.1002/cne.903350307. PubMed: 7901247.
32. Fox K, Sato H, Daw N (1989) The Location and Function of NMDA Receptors in Cat and Kitten Visual Cortex. J Neurosci 9: 2443-2454. PubMed: 2568409.
33. Fukuda M, Hata Y, Ohshima M, Tsumoto T (1998) Role of NMDA receptors in the propagation of excitation in rat visual cortex as studied by optical imaging. Neurosci Res 31: 9-21. doi:10.1016/S0168-0102(98)00018-2. PubMed: 9704974.
34. Kurylo DD, Gazes Y (2008) Effects of Ketamine on perceptual grouping in rats. Physiol Behav 95: 152-156. doi:10.1016/j.physbeh.2008.05.012. PubMed: 18571682.
35. Spruston N, Jonas P, Sakmann B (1995) Dendritic glutamate receptor channels in rat hippocampal CA3 and CA1 pyramidal neurons. J Physiol 482: 325-352. PubMed: 7536248.
36. Durstewitz D (2009) Implications of synaptic biophysics for recurrent network dynamics and active memory. Neural Netw 22: 1189-1200. doi:10.1016/j.neunet.2009.07.016. PubMed: 19647396.
37. Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11: 81-86. doi: 10.1016/0165-6147(90)90323-Z. PubMed: 2156365.
38. Snyder GL, Galdi S, Hendrick JP, Hemmings HC (2007) General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo. Neuropharmacology 53: 619-630. doi:10.1016/j. neuropharm.2007.07.008. PubMed: 17826804.
39. Newcomer JW, Krystal JH (2001) NMDA receptor regulation of memory and behavior in humans. Hippocampus 11: 529-542. doi:10.1002/hipo.1069. PubMed: 11732706.
40. Karni A, Sagi D (1991) Where practice makes perfect in texture discrimination: evidence for primary visual cortex plasticity. Proc Natl Acad Sci U S A 88: 4966-4970. doi:10.1073/pnas.88.11.4966. PubMed: 2052578.
41. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Psychol 47: 211-218. doi:10.1111/j.2044-8341.1974.tb02285.x.
42. Pourtois G, Rauss KS, Vuilleumier P, Schwartz S (2008) Effects of perceptual learning on primary visual cortex activity in humans. Vision Res 48: 55-62. doi:10.1016/j.visres.2007.10.027. PubMed: 18082238.
43. Schwartz S, Maquet P, Frith C (2002) Neural correlates of perceptual learning: a functional MRI study of visual texture discrimination. Proc Natl Acad Sci U S A 99: 17137-17142. doi:10.1073/pnas.242414599. PubMed: 12446842.
44. Yotsumoto Y, Watanabe T (2008) Defining a link between perceptual learning and attention. PLOS Biol 6: e221. doi:10.1371/journal.pbio.0060221. PubMed: 18752357.
45. Danion JM, Zimmermann M-A, Willard-Schroeder D, Grangé D, Singer L (1989) Diazepam induces a dissociation between explicit and implicit memory. Psychopharmacology 99: 238-243. doi:10.1007/BF00442815. PubMed: 2508161.
46. Gift AG (1989) Visual Analogue Scales Measurement of Subjective Phenomena. Nurs Res, 38: 286-288. PubMed: 2678015.
47. Joyce CR, Zutshi DW, Hrubes V, Mason RM (1975) Comparison of fixed interval and visual analogue scales for rating chronic pain. Eur J Clin Pharmacol 8: 415-420. doi:10.1007/BF00562315. PubMed: 1233242.
48. Luria RE (1975) The validity and reliability of the visual analogue mood scale. J Psychiatr Res 12: 51-57. doi:10.1016/0022-3956(75)90020-5. PubMed: 806683.
49. van Loon AM, Scholte HS, van Gaal S, van der Hoort BJJ, Lamme VAF (2012) GABA A Agonist Reduces Visual Awareness: A Masking - EEG Experiment. Journal of Cognitive Neuroscience 24: 965-974.
50. Müller CP, Pum ME, Amato D, Schüttler J, Huston JP et al. (2011) The in vivo neurochemistry of the brain during general anesthesia. J Neurochem 119: 419-446. doi:10.1111/j.1471-4159.2011.07445.x. PubMed: 21883214.
51. Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N et al. (2012) Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs 26: 189-204. doi:10.2165/11599770-000000000-00000. PubMed: 22303887.
52. Kocsis B, Brown RE, McCarley RW, Hajos M (2013) Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits. CNS Neurosci Ther 19: 437-447. doi: 10.1111/cns.12081. PubMed: 23611295.
53. Chou YC, Liao JF, Chang WY, Lin MF, Chen CF (1999) Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res 821: 516-519. doi:10.1016/S0006-8993(99)01125-7. PubMed: 10064839.
54. Herrero JL, Roberts MJ, Delicato LS, Gieselmann MA, Dayan P et al. (2008) Acetylcholine contributes through muscarinic receptors to attentional modulation in V1. Nature 454: 1110-1114. doi:10.1038/nature07141. PubMed: 18633352.
55. Chizh BA (2007) Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. J Psychopharmacol 21: 259-271. doi: 10.1177/0269881105062484. PubMed: 17591654.
56. Kotermanski SE, Johnson JW, Thiels E (2013) Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Pharmacol Biochem Behav 109: 67-76. doi: 10.1016/j.pbb.2013.05.005. PubMed: 23665480.
57. Nikiforuk A, Gołembiowska K, Popik P (2010) Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. Eur Neuropsychopharmacol 20: 37-48. doi:10.1016/S0924-977X(10)70045-6. PubMed: 19729284.
58. Sato K, Wu J, Kikuchi T, Wang Y, Watanabe I et al. (1996) Differential effects of ketamine and pentobarbitone on acetylcholine release from the rat hippocampus and striatum. Br J Anaesth 77: 381-384. doi: 10.1093/bja/77.3.381. PubMed: 8949815.
59. Kikuchi T, Wang Y, Shinbori H, Sato K, Okumura F (1997) Effects of ketamine and pentobarbitone on acetylcholine release from the rat frontal cortex in vivo. Br J Anaesth 79: 128-130. doi:10.1093/bja/79.1.128. PubMed: 9301402.
60. Nelson CL, Burk JA, Bruno JP, Sarter M (2002) Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology 161: 168-179. doi:10.1007/s00213-002-1004-7. PubMed: 11981597.
61. Abel KM, Allin MP, Hemsley DR, Geyer MA (2003) Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology 44: 729-737. doi:10.1016/S0028-3908(03)00073-X. PubMed: 12681371.
62. Abel KM, Allin MPG, Kucharska-Pietura K, David A, Andrew C et al. (2003) Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport 14: 387-391. PubMed: 12634489.
63. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR et al. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351-354. doi:10.1016/S0006-3223(99)00230-9. PubMed: 10686270.
64. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal. Cortex. 17: 2921-2927.
65. Maeng S, Zarate CAJ, Du J, Schloesser RJ, McCammon J et al. (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63: 349-352. doi:10.1016/j.biopsych.2007.05.028. PubMed: 17643398.
66. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF et al. (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475: 91-95. doi:10.1038/nature10130. PubMed: 21677641.
67. Szewczyk B, Pałucha-Poniewiera A, Poleszak E, Pilc A, Nowak G (2012) Investigational NMDA receptor modulators for depression. Expert Opin Invest Drugs 21: 91-102. doi: 10.1517/13543784.2012.638916.
68. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM et al. (2010) mTORdependent synapse formation underlies rapid antidepressant effects of NMDA antagonist. Science 329: 959-964. doi:10.1126/science.1190287. PubMed: 20724638.
69. Duman RS, Li N, Liu R-J, Duric V, Aghajanian G (2012) Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62: 35-41. doi:10.1016/j.neuropharm.2011.08.044. PubMed: 21907221.
70. Kavalali ET, Monteggia LM (2012) Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 169: 1150-1156. doi:10.1176/appi.ajp.2012.12040531. PubMed: 23534055.
71. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R et al. (2006) A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Arch Gen Psychiatry 63: 856-864. doi: 10.1001/archpsyc.63.8. 856. PubMed: 16894061.
72. Oye I, Paulsen O, Maurset A (1992) Effects of Ketamine on Sensory Perception: Evidence for a Role of N-Methyl-D-Aspartate Receptors. J Pharmacol Exp Ther 260: 1209-1213. PubMed: 1312163.
73. Lamme VAF (2000) Neural Mechanisms of Visual Awareness: A Linking Proposition. Brain Mind 1: 385-406. doi:10.1023/A: 1011569019782.
74. Boehler CN, Schoenfeld MA, Heinze H-J, Hopf J-M (2008) Rapid recurrent processing gates awareness in primary visual cortex. Proc Natl Acad Sci U S A 105: 8742-8747. doi:10.1073/pnas.0801999105. PubMed: 18550840.
75. Honey RAE, Honey GD, O'Loughlin C, Sharar SR, Kumaran D et al. (2004) Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study. Neuropsychopharmacology 29: 1203-1214. doi:10.1038/sj.npp.1300438. PubMed: 15100698.
76. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R et al. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214. doi: 10.1001/archpsyc.1994.03950030035004. PubMed: 8122957.
77. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar D et al. (1996) NMDA Receptor Function And Human Cognition: The Effects Of Ketamine In Healthy Volunteers. Neuropsychopharmacology 14: 301-307. doi:10.1016/0893-133X(95)00137- 3. PubMed: 8703299.
78. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D et al. (2000) Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers. Arch Gen Psychiatry 57: 35-39.
79. Taffe MA, Davis SA, Gutierrez T, Gold LH (2002) Ketamine impairs multiple cognitive domains in rhesus monkeys. Drug Alcohol Depend 68: 175-187. doi:10.1016/S0376-8716(02)00194-1. PubMed: 12234647.
80. Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N et al. (2005) Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology 179: 303-309. doi:10.1007/s00213-004-1982-8. PubMed: 15309376.
81. Passie T, Karst M, Wiese B, Emrich HM, Schneider U (2005) Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. Neuropsychobiology 51: 226-233. doi:10.1159/000085724. PubMed: 15897673.
82. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811-816. doi: 10.1016/S0006-3223(97)00556-8. PubMed: 9611670.
83. Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A et al. (1999) Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology 145: 193-204. doi:10.1007/s002130051049. PubMed: 10463321.
84. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK et al. (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106-118. doi:10.1016/S0893-133X(98)00067-0. PubMed: 9885791.
85. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug: serenyl. Arch Neurol Psychiatry 71: 363-369.
86. Harborne GC, Watson FL, Healy DT, Groves L (1996) The The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers. J Psychopharmacol 10: 134-140. doi:10.1177/026988119601000208. PubMed: 22302890.
87. Oranje B, van Berckel BN, Kemner C, van Ree JM, Kahn RS et al. (2000) The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22: 293-302. doi: 10.1016/S0893-133X(99)00118-9. PubMed: 10693157.
88. Rowland LM (2005) Subanesthetic Ketamine: How It Alters Physiology and Behavior in Humans. Aviat Space Environ Med 76: C52-C58. PubMed: 16018330.
89. Morgan CJA, Curran HV (2006) Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology: 408-424. PubMed: 17006715.